Capital with a shipyard attached: Seaspan launches a CVC fund, Hitachi Ventures leads a $6.5m round

Corporate venture capital is usually pictured as the investing arm of a technology group: Google set up a later-stage fund in 2013-2014, later named CapitalG; Microsoft set up a venture fund in March 2016, now M12. Seaspan Vancouver Shipyards' 19 October 2026 announcement belongs to a different category: a heavy-industry company creating a fund to back domestic small and medium-sized businesses in defence, marine and dual-use applications.

What this company is selling is not money

According to the announcement, the fund will give Canadian companies three things: growth capital, shipbuilding expertise and pathways to market. The order matters. For an early-stage marine technology company, access to a yard, to qualification processes and to a shipbuilder's contracts is hard to replace with cash from a purely financial fund. That is why industrial CVC can win deals without offering the highest valuation.

The other side is a geographic and legal constraint. The fund is announced for Canadian businesses. Strategic capital in defence and dual-use is almost always tied to corporate nationality, domestic supply chains and public procurement rules. Founders outside that perimeter should not treat such funds as an addressable capital source, however well the product fits.

CVC has moved down to rounds of a few million dollars

The classic CVC model is late entry, once a product has customers and technical risk has fallen, which is the logic behind the later-stage fund Google set up in 2013-2014. October 2026 shows different behaviour: Hitachi Ventures led Trmeric's $6.5m round, an agentic platform described as powering $1bn in enterprise transformation. When an industrial group's investment arm leads at that size, what it buys is not a large stake but an early observation post and first call on deploying the technology inside the group.

Independent capital is not conceding the ground. NVM Ventures held a EUR 23.6m first close for a dual-use strategy, the same theme Seaspan is targeting but without a corporate parent's constraints. A third variant is the institution-partnered fund: in May 2025 General Catalyst and Speedinvest launched a GBP 30m medical technology fund with the UK's National Health Service. All three models sell the same non-cash product: access to a large customer.

The price is in the term sheet, not in the valuation

When the investor is also a customer or prime contractor, three clauses deserve close reading: pre-emption or a right of first refusal over a sale of the company; exclusive distribution or sector exclusivity; and veto rights attached to share transfers. Each is reasonable from the corporate side, and each narrows the future buyer set. At the early stage, that cost does not show up in the valuation; it shows up in the exit path three to five years later.